Viral hepatitis, hallmarks and molecular features

Authors

  • Orlando Vargas-Sierra Universidad Anáhuac Cancún, Campus Internacional
  • Nathalia Beatriz Camara-Medina Universidad Anáhuac Cancún, Campus Internacional https://orcid.org/0000-0003-2286-1357
  • Nicole Vincze-Galicia Universidad Anáhuac Cancún, Campus Internacional https://orcid.org/0000-0002-1597-0400
  • Camila Uriarte-Figueroa Universidad Anáhuac Cancún, Campus Internacional https://orcid.org/0000-0003-1053-9862
  • Javiera Pozo-Montalvo Universidad Anáhuac Cancún, Campus Internacional https://orcid.org/0000-0001-5716-0054
  • Perla Yaceli Uc-Uc Universidad Anáhuac Cancún, Campus Internacional
  • Daniela Rebolledo-Solleiro Universidad Anáhuac Cancún, Campus Internacional

DOI:

https://doi.org/10.36105/psrua.2023v3n5.02

Keywords:

hepatitis, virus, liver, unknown etiology

Abstract

Hepatitis is a liver inflammation which has different etiologies, it can be caused pharmacologically or can be associated with fatty liver or alcohol consumption. However, viral infection as the most important cause. Recently, the World Health Organization (WHO) has published reports of outbreaks of hepatitis of unknown etiology in several countries in children less than 16 years. In this review we describe the general aspects of viral hepatitis, the molecular description of the hepatotropic viruses, laboratory findings, molecular diagnosis, prevention strategies. In addition, the main characteristics of some viruses that are not hepatotropic but have been previously reported to be related to some types of hepatitis are mentioned. Finally, a brief description of new cases of hepatitis of unknown origin is given and the adverse effects of SARS COV-2 vaccines are briefly discussed.

Downloads

Download data is not yet available.

PLUMX metrics

References

Liu D, Yu Q, Li Z, Zhang L, Hu M, Wang C, et al. UGT1A1 dysfunction increases liver burden and aggravates hepatocyte damage caused by long-term bilirubin metabolism disorder. Biochemical pharmacology. 2021;190:114592. https://doi.org/10.1016/j.bcp.2021.114592 DOI: https://doi.org/10.1016/j.bcp.2021.114592

Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chemico-biological interactions. 2007;168(1):66-73. https://doi.org/10.1016/j.cbi.2006.12.003 DOI: https://doi.org/10.1016/j.cbi.2006.12.003

Paulusma CC, Lamers WH, Broer S, van de Graaf SFJ. Amino acid metabolism, transport and signalling in the liver revisited. Biochemical pharmacology. 2022;201:115074. https://doi.org/10.1016/j.bcp.2022.115074 DOI: https://doi.org/10.1016/j.bcp.2022.115074

Higashi N, Sato M, Kojima N, Irie T, Kawamura K, Mabuchi A, et al. Vitamin A storage in hepatic stellate cells in the regenerating rat liver: with special reference to zonal heterogeneity. The anatomical record Part A, Discoveries in molecular, cellular, and evolutionary biology. 2005;286(2):899-907. https://doi.org/10.1002/ar.a.20230 DOI: https://doi.org/10.1002/ar.a.20230

Medicine JH. Liver: Anatomy and Functions [Available from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/liver-anatomy-and-functions

Schulz M, Trebicka J. Acute-on-chronic liver failure: a global disease. Gut. 2022;71(1):5-6. https://doi.org/10.1136/gutjnl-2020-323973 DOI: https://doi.org/10.1136/gutjnl-2020-323973

Lee Y, Friedman SL. Fibrosis in the liver: acute protection and chronic disease. Progress in molecular biology and translational science. 2010;97:151-200. https://doi.org/10.1016/B978-0-12-385233-5.00006-4 DOI: https://doi.org/10.1016/B978-0-12-385233-5.00006-4

Chen J, Shu Q, Zhao ZY. Response to the outbreak of severe acute hepatitis of unknown origin in children. World journal of pediatrics : WJP. 2022. https://doi.org/10.1007/s12519-022-00577-7 DOI: https://doi.org/10.1007/s12519-022-00577-7

Devictor D, Tissieres P, Durand P, Chevret L, Debray D. Acute liver failure in neonates, infants and children. Expert review of gastroenterology & hepatology. 2011;5(6):717-29. https://doi.org/10.1586/egh.11.57 DOI: https://doi.org/10.1586/egh.11.57

Devictor D, Tissieres P, Afanetti M, Debray D. Acute liver failure in children. Clinics and research in hepatology and gastroenterology. 2011;35(6-7):430-7. https://doi.org/10.1016/j.clinre.2011.03.005 DOI: https://doi.org/10.1016/j.clinre.2011.03.005

Jeong SH, Lee HS. Hepatitis A: clinical manifestations and management. Intervirology. 2010;53(1):15-9. https://doi.org/10.1159/000252779 DOI: https://doi.org/10.1159/000252779

Chen CY, Hajinicolaou C, Walabh P, Ingasia LAO, Song E, Kramvis A. Molecular characterization of hepatitis B virus (HBV) isolated from a pediatric case of acute lymphoid leukemia, with a delayed response to antiviral treatment: a case report. BMC pediatrics. 2022;22(1):168. https://doi.org/10.1186/s12887-022-03204-6 DOI: https://doi.org/10.1186/s12887-022-03204-6

World-Health-Organization. Multi-Country – Acute, severe hepatitis of unknown origin in children 2022 [05/17/2022]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON376

Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World journal of hepatology. 2012;4(3):68-73. https://doi.org/10.4254/wjh.v4.i3.68 DOI: https://doi.org/10.4254/wjh.v4.i3.68

Ismail F, Alsharif F, El-Garawani I, Abdelsameea E. Acute Hepatitis A Virus Infection in Tobruk, Eastern Libya: Increasing Trends After 2017. Food and environmental virology. 2022;14(1):89-93. https://doi.org/10.1007/s12560-021-09499-5 DOI: https://doi.org/10.1007/s12560-021-09499-5

Koenig KL, Shastry S, Burns MJ. Hepatitis A Virus: Essential Knowledge and a Novel Identify-Isolate-Inform Tool for Frontline Healthcare Providers. The western journal of emergency medicine. 2017;18(6):1000-7. https://doi.org/10.5811/westjem.2017.10.35983 DOI: https://doi.org/10.5811/westjem.2017.10.35983

Ghosh CK, Miah SA, Hasan MA, Chowdhury M, Miah AR. Prolonged Jaundice in a Patient with Coexisting Hepatitis A Virus Infection and Wilson's Disease. Mymensingh medical journal : MMJ. 2021;30(2):559-61.

Sarma MS, Ravindranath A. Pediatric acute viral hepatitis with atypical variants: Clinical dilemmas and natural history. World journal of hepatology. 2022;14(5):944-55. 1https://doi.org/0.4254/wjh.v14.i5.944 DOI: https://doi.org/10.4254/wjh.v14.i5.944

Lin C, Huang Y, Luo L, Fang F, Zhang J, Xun Z, et al. Adenosine Triphosphate in Serum as a Promising Biomarker for Differential Diagnosis of Hepatitis B Disease Progression. Frontiers in immunology. 2022;13:927761. https://doi.org/10.3389/fimmu.2022.927761 DOI: https://doi.org/10.3389/fimmu.2022.927761

Harada T, Komatsu H, Inui A, Tsunoda T, Hashimoto T, Fujisawa T. Hepatitis B virus DNA in the fingernails and hair of children with acute hepatitis B. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2022;28(1):82-6. https://doi.org/10.1016/j.jiac.2021.08.014 DOI: https://doi.org/10.1016/j.jiac.2021.08.014

de Almeida Ponde RA. Detection of the serological markers hepatitis B virus surface antigen (HBsAg) and hepatitis B core IgM antibody (anti-HBcIgM) in the diagnosis of acute hepatitis B virus infection after recent exposure. Microbiology and immunology. 2022;66(1):1-9. https://doi.org/10.1111/1348-0421.12943 DOI: https://doi.org/10.1111/1348-0421.12943

Koulouris A, Tsagkaris C, Spyrou V, Pappa E, Troullinou A, Nikolaou M. Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options. Journal of hepatocellular carcinoma. 2021;8:387-401. https://doi.org/10.2147/JHC.S300182 DOI: https://doi.org/10.2147/JHC.S300182

Marascio N, Rotundo S, Quirino A, Matera G, Liberto MC, Costa C, et al. Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice. World journal of gastroenterology. 2022;28(12):1226-38. https://doi.org/10.3748/wjg.v28.i12.1226 DOI: https://doi.org/10.3748/wjg.v28.i12.1226

Pisano MB, Giadans CG, Flichman DM, Re VE, Preciado MV, Valva P. Viral hepatitis update: Progress and perspectives. World journal of gastroenterology. 2021;27(26):4018-44. https://doi.org/10.3748/wjg.v27.i26.4018 DOI: https://doi.org/10.3748/wjg.v27.i26.4018

Razavi H. Global Epidemiology of Viral Hepatitis. Gastroenterology clinics of North America. 2020;49(2):179-89. https://doi.org/10.1016/j.gtc.2020.01.001 DOI: https://doi.org/10.1016/j.gtc.2020.01.001

Thuener J. Hepatitis A and B Infections. Primary care. 2017;44(4):621-9. https://doi.org/10.1016/j.pop.2017.07.005 DOI: https://doi.org/10.1016/j.pop.2017.07.005

McKnight KL, Lemon SM. Hepatitis A Virus Genome Organization and Replication Strategy. Cold Spring Harbor perspectives in medicine. 2018;8(12). https://doi.org/10.1101/cshperspect.a033480 DOI: https://doi.org/10.1101/cshperspect.a033480

Shi G, Suzuki T. Molecular Basis of Encapsidation of Hepatitis C Virus Genome. Front Microbiol. 2018;9:396. https://doi.org/10.3389/fmicb.2018.00396 DOI: https://doi.org/10.3389/fmicb.2018.00396

Castaneda D, Gonzalez AJ, Alomari M, Tandon K, Zervos XB. From hepatitis A to E: A critical review of viral hepatitis. World journal of gastroenterology. 2021;27(16):1691-715. https://doi.org/10.3748/wjg.v27.i16.1691 DOI: https://doi.org/10.3748/wjg.v27.i16.1691

Svicher V, Salpini R, Piermatteo L, Carioti L, Battisti A, Colagrossi L, et al. Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B. Gut. 2021;70(12):2337-48. https://doi.org/10.1136/gutjnl-2020-323300 DOI: https://doi.org/10.1136/gutjnl-2020-323300

Tang LSY, Covert E, Wilson E, Kottilil S. Chronic Hepatitis B Infection: A Review. Jama. 2018;319(17):1802-13. https://doi.org/10.1001/jama.2018.3795 DOI: https://doi.org/10.1001/jama.2018.3795

Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5 Suppl):S13-21. https://doi.org/10.1002/hep.22881 DOI: https://doi.org/10.1002/hep.22881

Ji Q, Chu X, Zhou Y, Liu X, Zhao W, Ye W. Safety and efficacy of grazoprevir/elbasvir in the treatment of acute hepatitis C in hemodialysis patients. Journal of medical virology. 2022;94(2):675-82. https://doi.org/10.1002/jmv.27374 DOI: https://doi.org/10.1002/jmv.27374

Netter HJ, Barrios MH, Littlejohn M, Yuen LKW. Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin. Front Microbiol. 2021;12:652962. https://doi.org/10.3389/fmicb.2021.652962 DOI: https://doi.org/10.3389/fmicb.2021.652962

Taylor JM. Hepatitis D Virus Replication. Cold Spring Harbor perspectives in medicine. 2015;5(11). https://doi.org/10.1101/cshperspect.a021568 DOI: https://doi.org/10.1101/cshperspect.a021568

Xing L, Li TC, Mayazaki N, Simon MN, Wall JS, Moore M, et al. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem. 2010;285(43):33175-83. https://doi.org/10.1074/jbc.M110.106336 DOI: https://doi.org/10.1074/jbc.M110.106336

Stapleton JT. Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease? Frontiers in immunology. 2022;13:887760. https://doi.org/10.3389/fimmu.2022.887760 DOI: https://doi.org/10.3389/fimmu.2022.887760

Ludowyke N, Phumiphanjarphak W, Apiwattanakul N, Manopwisedjaroen S, Pakakasama S, Sensorn I, et al. Target Enrichment Metagenomics Reveals Human Pegivirus-1 in Pediatric Hematopoietic Stem Cell Transplantation Recipients. Viruses. 2022;14(4). https://doi.org/10.3390/v14040796 DOI: https://doi.org/10.3390/v14040796

Yu Y, Wan Z, Wang JH, Yang X, Zhang C. Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication. Virulence. 2022;13(1):324-41. https://doi.org/10.1080/21505594.2022.2029328 DOI: https://doi.org/10.1080/21505594.2022.2029328

Xiang J, Klinzman D, McLinden J, Schmidt WN, LaBrecque DR, Gish R, et al. Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol. 1998;72(4):2738-44. https://doi.org/10.1128/jvi.72.4.2738-2744.1998 DOI: https://doi.org/10.1128/JVI.72.4.2738-2744.1998

Ranjbar MM, Ghorban K, Alavian SM, Keyvani H, Dadmanesh M, Roayaei Ardakany A, et al. GB Virus C/Hepatitis G Virus Envelope Glycoprotein E2: Computational Molecular Features and Immunoinformatics Study. Hepat Mon. 2013;13(12):e15342. https://doi.org/10.5812/hepatmon.15342 DOI: https://doi.org/10.5812/hepatmon.15342

Khan U, Uzair Ahmad R, Ullah Z, Fida T, Shehryar M. Parvovirus b19-Induced Acute Hepatitis With Hepatosplenomegaly and Polyarthropathy. Cureus. 2022;14(1):e21494. https://doi.org/10.7759/cureus.21494 DOI: https://doi.org/10.7759/cureus.21494

Bhattarai AM, Dhakal B, Rokaya P, Karki A, Gurung S, Baral S. Aplastic anemia induced by human parvovirus B19 infection in an immunocompetent adult male without prior hematological disorders: A case report. Annals of medicine and surgery. 2022;79:103998. https://doi.org/10.1016/j.amsu.2022.103998 DOI: https://doi.org/10.1016/j.amsu.2022.103998

Alves ADR, Langella BB, Lima MMS, Coelho W, Cubel Garcia RCN, Cardoso CAA, et al. Evaluation of Molecular Test for the Discrimination of "Naked" DNA from Infectious Parvovirus B19 Particles in Serum and Bone Marrow Samples. Viruses. 2022;14(4). https://doi.org/10.3390/v14040843 DOI: https://doi.org/10.3390/v14040843

Luo Y, Qiu J. Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol. 2015;10(2):155-67. https://doi.org/10.2217/fvl.14.103 DOI: https://doi.org/10.2217/fvl.14.103

Wongwiwat W, Fournier B, Bassano I, Bayoumy A, Elgueta Karstegl C, Styles C, et al. Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases. J Virol. 2022;96(12):e0039422. https://doi.org/10.1128/jvi.00394-22. DOI: https://doi.org/10.1128/jvi.00394-22

Da Cunha T, Mago S, Bath RK. Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis. Cureus. 2022;14(4):e24552. https://doi.org/10.7759/cureus.24552 DOI: https://doi.org/10.7759/cureus.24552

Cunningham C, Gatherer D, Hilfrich B, Baluchova K, Dargan DJ, Thomson M, et al. Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J Gen Virol. 2010;91(Pt 3):605-15. https://doi.org/10.1099/vir.0.015891-0 DOI: https://doi.org/10.1099/vir.0.015891-0

Santpere G, Darre F, Blanco S, Alcami A, Villoslada P, Mar Albà M, et al. Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project. Genome Biol Evol. 2014;6(4):846-60. https://doi.org/10.1093/gbe/evu054 DOI: https://doi.org/10.1093/gbe/evu054

Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Frontiers in Oncology. 2018;8. https://doi.org/10.3389/fonc.2018.00211 DOI: https://doi.org/10.3389/fonc.2018.00211

Chan A, Bazerbachi F, Hanson B, Alraies MC, Duran-Nelson A. Cytomegalovirus hepatitis and pancreatitis in the immunocompetent. The Ochsner journal. 2014;14(2):295-9.

Zahid M, Ali N, Saad M, Kelly P, Ortiz A. Acute Cytomegalovirus (CMV) Hepatitis in an Immunocompetent Adult. The American journal of case reports. 2020;21:e925495. https://doi.org/10.12659/AJCR.925495 DOI: https://doi.org/10.12659/AJCR.925495

Sitnik R, Maluf MM, Oliveira KG, Siqueira RA, Ferreira C, Mangueira CLP, et al. Study protocol: epidemiological and clinical characteristics of acute viral hepatitis in Brazilian health services. BMJ open. 2021;11(7):e045852. https://doi.org/10.1136/bmjopen-2020-045852 DOI: https://doi.org/10.1136/bmjopen-2020-045852

Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nature reviews Disease primers. 2015;1:15016. https://doi.org/10.1038/nrdp.2015.16 DOI: https://doi.org/10.1038/nrdp.2015.16

Tombácz D, Prazsák I, Moldován N, Szűcs A, Boldogkői Z. Lytic Transcriptome Dataset of Varicella Zoster Virus Generated by Long-Read Sequencing. Frontiers in Genetics. 2018;9. https://doi.org/10.3389/fgene.2018.00460 DOI: https://doi.org/10.3389/fgene.2018.00460

Gardner CL, Ryman KD. Yellow fever: a reemerging threat. Clin Lab Med. 2010;30(1):237-60. https://doi.org/10.1016/j.cll.2010.01.001 DOI: https://doi.org/10.1016/j.cll.2010.01.001

Nwaiwu AU, Musekiwa A, Tamuzi JL, Sambala EZ, Nyasulu PS. The incidence and mortality of yellow fever in Africa: a systematic review and meta-analysis. BMC infectious diseases. 2021;21(1):1089. https://doi.org/10.1186/s12879-021-06728-x. DOI: https://doi.org/10.1186/s12879-021-06728-x

Rezende IM, Pereira LS, Fradico JRB, Pascoal Xavier MA, Alves PA, Campi-Azevedo AC, et al. Late-Relapsing Hepatitis after Yellow Fever. Viruses. 2020;12(2). https://doi.org/10.3390/v12020222 DOI: https://doi.org/10.3390/v12020222

Das PK, Kielian M. Molecular and Structural Insights into the Life Cycle of Rubella Virus. J Virol. 2021. https://doi.org/10.1128/JVI.02349-20 DOI: https://doi.org/10.1128/JVI.02349-20

Onji M, Kumon I, Kanaoka M, Miyaoka H, Ohta Y. Intrahepatic lymphocyte subpopulations in acute hepatitis in an adult with rubella. The American journal of gastroenterology. 1988;83(3):320-2.

Arai M, Wada N, Maruyama K, Nomiyama T, Tanaka S, Okazaki I. Acute hepatitis in an adult with acquired rubella infection. Journal of gastroenterology. 1995;30(4):539-42. https://doi.org/10.1007/BF02347575 DOI: https://doi.org/10.1007/BF02347575

Kang HJ, Kim YJ, Lee HM, Nam JG, Kim SS. Complete Genome Sequence of a Genotype 2B Rubella Virus Isolated in South Korea in 2015. Genome Announc. 2017;5(38). https://doi.org/10.1128/genomeA.00940-17 DOI: https://doi.org/10.1128/genomeA.00940-17

Mucke MM, Zeuzem S. The recent outbreak of acute severe hepatitis in children of unknown origin - what is known so far. Journal of hepatology. 2022;77(1):237-42. https://doi.org/10.1016/j.jhep.2022.05.001 DOI: https://doi.org/10.1016/j.jhep.2022.05.001

Ismail AM, Lee JS, Lee JY, Singh G, Dyer DW, Seto D, et al. Adenoviromics: Mining the Human Adenovirus Species D Genome. Frontiers in Microbiology. 2018;9. https://doi.org/10.3389/fmicb.2018.02178 DOI: https://doi.org/10.3389/fmicb.2018.02178

Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology. 2002;122(6):1554-68. https://doi.org/10.1053/gast.2002.33428 DOI: https://doi.org/10.1053/gast.2002.33428

Liang SB, Hou WB, Zheng RX, Liang CH, Yan LJ, Wang HN, et al. Compound glycyrrhizin injection for improving liver function in children with acute icteric hepatitis: A systematic review and meta-analysis. Integrative medicine research. 2022;11(1):100772. https://doi.org/10.1016/j.imr.2021.100772 DOI: https://doi.org/10.1016/j.imr.2021.100772

Choi JW, Son HJ, Lee SS, Jeon H, Cho JK, Kim HJ, et al. Acute hepatitis E virus superinfection increases mortality in patients with cirrhosis. BMC infectious diseases. 2022;22(1):62. https://doi.org/10.1186/s12879-022-07050-w DOI: https://doi.org/10.1186/s12879-022-07050-w

Zhao D, Zhang X, Tang Y, Guo P, Ai R, Hou M, et al. Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology. Journal of hepatocellular carcinoma. 2022;9:389-403. https://doi.org/10.2147/JHC.S357380 DOI: https://doi.org/10.2147/JHC.S357380

Bruguera M. Prevención de las hepatitis virales. Enferm Infecc Microbiol Clin 2006;24(10):649-56. DOI: https://doi.org/10.1157/13095377

Hepatitis B [cited 2022 10 october ]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.

Zhang LY, Huang LS, Yue YH, Fawaz R, Lim JK, Fan JG. Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak. Journal of clinical and translational hepatology. 2022;10(3):522-30. https://doi.org/10.14218/JCTH.2022.00281. DOI: https://doi.org/10.14218/JCTH.2022.00281

Baker JM, Buchfellner M, Britt W, Sanchez V, Potter JL, Ingram LA, et al. Acute hepatitis and adenovirus infection among children-Alabama, October 2021-February 2022. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2022;22(7):1919-21. https://doi.org/10.1111/ajt.16665 DOI: https://doi.org/10.1111/ajt.16665

Li J, Hu W, Zhang JY, Wang FS. Pediatric Acute Severe Hepatitis of Unknown Origin: What is New? Journal of clinical and translational hepatology. 2022;10(3):509-14. https://doi.org/10.14218/JCTH.2022.00247 DOI: https://doi.org/10.14218/JCTH.2022.00247

World-Health-Organization. Severe acute hepatitis of unknown aetiology in children Multi country 2022 [cited 2022 26/07/2022]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON400

Coronavirus (COVID-19) Vaccinations 2022 [cited 2022 october]. Available from: https://ourworldindata.org/covid-vaccinations.

Asgarzdeh A, Habibzadeh S, Asghariazar V, Safarzadeh E. Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination. Clinics and research in hepatology and gastroenterology. 2022:102028. https://doi.org/10.1016/j.clinre.2022.102028 DOI: https://doi.org/10.1016/j.clinre.2022.102028

Mann R, Sekhon S, Sekhon S. Drug-Induced Liver Injury After COVID-19 Vaccine. Cureus. 2021;13(7):e16491. https://doi.org/10.7759/cureus.16491 DOI: https://doi.org/10.7759/cureus.16491

Ghorbani H, Rouhi T, Vosough Z, Shokri-Shirvani J. Drug-induced hepatitis after Sinopharm COVID-19 vaccination: A case study of a 62-year-old patient. Int J Surg Case Rep. 2022;93:106926. https://doi.org/10.1016/j.ijscr.2022.106926 DOI: https://doi.org/10.1016/j.ijscr.2022.106926

Downloads

Published

2023-06-14

How to Cite

Vargas-Sierra, O. ., Camara-Medina, N. B. ., Vincze-Galicia, N., Uriarte-Figueroa, C. ., Pozo-Montalvo, J. ., Uc-Uc, P. Y. ., & Rebolledo-Solleiro, D. (2023). Viral hepatitis, hallmarks and molecular features. Proceedings of Scientific Research Universidad Anáhuac. Multidisciplinary Journal of Healthcare, 3(5), 14–28. https://doi.org/10.36105/psrua.2023v3n5.02

Issue

Vol. 3 No. 5 (2023): Proceedings of Scientific Research Universidad Anáhuac

Section

Review Articles

License

Copyright (c) 2023 Orlando Vargas-Sierra, Nathalia Beatriz Camara-Medina, Nicole Vincze-Galicia, Camila Uriarte-Figueroa, Javiera Pozo-Montalvo, Perla Yaceli Uc-Uc, Daniela Rebolledo-Solleiro

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All the intellectual content found in this publication is licensed to the consumer public under the figure of Creative Commons©, unless the author of said content has agreed otherwise or limited said faculty to "Proceedings of Scientific Research Universidad Anáhuac. Multidisciplinary Journal of Healthcare©" or "Universidad Anáhuac Mexico©" in writing and expressly.

Proceedings of Scientific Research Universidad Anáhuac. Multidisciplinary Journal of Healthcare is distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The author retains the economic rights without restrictions and guarantees the journal the right to be the first publication of the work. The author is free to publish his article in any other medium, such as an institutional repository.